| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/10/2007 | US7202350 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives, are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 04/10/2007 | US7202245 Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines |
| 04/05/2007 | WO2007038519A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 04/05/2007 | WO2007036138A1 5H-THIENO [3,4-c] PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR |
| 04/05/2007 | WO2006124874A3 Inhibitors of b-raf kinase |
| 04/05/2007 | WO2006058338A3 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| 04/05/2007 | US20070078152 Piperidine derivatives |
| 04/05/2007 | US20070078131 p38 mitogen-activated protein (MAP) kinase inhibitors such as Ethyl 3-(3-methylbenzoyl)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate, used in the treatment and/or prevention of autoimmune diseases or inflammatory disorders; antiinflammatory agents |
| 04/05/2007 | US20070078125 Arylamine mch r1 antagonists |
| 04/05/2007 | CA2623965A1 5h-thieno (3,4-c) pyrrole-4, 6-dione derivatives against cell releasing tumor necrosis factor |
| 04/05/2007 | CA2623228A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 04/05/2007 | CA2623026A1 Fused tetracyclic mglur1 antagonists as therapeutic agents |
| 04/04/2007 | EP1768985A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 04/04/2007 | EP1768984A1 Thienopyrimidines useful as aurora kinase inhibitors |
| 04/04/2007 | EP1768983A2 Fused heterocyclic kinase inhibitors |
| 04/04/2007 | EP1768957A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 04/04/2007 | CN1942475A Substituted thieno - and thiazolo - [2, 3-d] pyridines as inhibitors of Tie2 |
| 04/04/2007 | CN1942474A Chemical compounds |
| 04/04/2007 | CN1942441A Sulfonyloxy derivatives |
| 04/04/2007 | CN1939923A Production of dozoan intermediate |
| 04/04/2007 | CN1939922A 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor |
| 04/04/2007 | CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
| 04/04/2007 | CN1308311C Novel pyridine- and quinoline-derivatives |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308305C Method for synthesizing imide base substituted endo compound |
| 04/03/2007 | US7199127 (2-chloropurin-9-yl)-tetrahydrothiophene-3,4-diols; anticarcinogenic agents selective to A3 adenosine receptors; breast cancer |
| 04/03/2007 | US7199119 Antiinflammation agents |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 03/29/2007 | WO2007035028A1 Novel resinate complex of s-clopidogrel and production method thereof |
| 03/29/2007 | WO2007035010A2 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus |
| 03/29/2007 | WO2007033937A1 Synthesis of cyclopentadienedithiophene derivatives |
| 03/29/2007 | WO2005110410A3 Kinase inhibitors as therapeutic agents |
| 03/29/2007 | US20070072924 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 03/29/2007 | US20070072912 Alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants |
| 03/29/2007 | US20070072845 Process for the preparation of olanzapine form 1 useful as antipsychotic drug |
| 03/28/2007 | EP1765829A1 Tricyclic compounds and their use as mglur1 antagonists |
| 03/28/2007 | EP1765828A1 AN IMPROVED PROCESS FOR THE PREPARATION OF 5,6 -DIHYDRO -4H-4(S)-ETHYLAMINO-6(S)-METHYLTHIENO[2,3-b] THIOPYRAN-2-SULFONAMIDE- 7,7 -DIOXIDE AND ITS SALT |
| 03/28/2007 | EP1765814A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists |
| 03/28/2007 | EP1256581B1 Preventive or therapeutic agents for gastric or esophageal regurgitation |
| 03/28/2007 | CN1938329A Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules |
| 03/28/2007 | CN1938320A Compounds and methods for treating dyslipidemia |
| 03/28/2007 | CN1938319A Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same |
| 03/28/2007 | CN1935811A 3-aryl-5,6-substituted thienopyrimidine-4-carbonyl-2-mercaptoacetonitrile, and its synthesizing method and use |
| 03/28/2007 | CN1307183C Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/27/2007 | US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 03/27/2007 | US7196085 Phthalazinone derivatives |
| 03/27/2007 | US7195925 Polymer having an upper critical solution temperature |
| 03/27/2007 | US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/22/2007 | WO2007032854A1 FUSED TRICYCLIC mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS |
| 03/22/2007 | WO2007032695A1 New salts of olanzapine and method of their preparation |
| 03/22/2007 | WO2007032023A2 A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof |
| 03/22/2007 | WO2007031428A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 03/22/2007 | WO2006098961A3 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity |
| 03/22/2007 | WO2006091847A3 Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| 03/22/2007 | WO2006078574A3 Mitotic kinesin inhibitors |
| 03/22/2007 | US20070063187 Switching element |
| 03/22/2007 | CA2621830A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 03/22/2007 | CA2619419A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 03/21/2007 | EP1764367A1 Thienopyridine derivatives |
| 03/21/2007 | EP1763531A1 Hepatitis c inhibitor peptide analogs |
| 03/21/2007 | EP1425282B1 Process for the preparation of diketopyrrolopyrroles |
| 03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
| 03/21/2007 | EP1313729B1 Design and synthesis of thiophene derived nlo materials for electro-optic applications |
| 03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7192968 Ethylenediamine derivatives |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/15/2007 | WO2007029345A1 Tyrosinase activity inhibitor |
| 03/15/2007 | WO2007029096A2 Novel polymorphic forms of clopidogrel hydrochloride |
| 03/15/2007 | WO2007029080A1 Preparation of form i of clopidogrel hydrochloride |
| 03/15/2007 | WO2007029037A2 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007028337A1 Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compounds |
| 03/15/2007 | WO2006025069A8 Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| 03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
| 03/15/2007 | CA2621448A1 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/14/2007 | EP1761571A1 Transition metal compound, ligand system., catalyst system and process for preparing polyolefins |
| 03/14/2007 | EP1761545A2 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 03/14/2007 | EP1761508A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 03/14/2007 | EP1761268A2 Pyrrolotriazine kinase inhibitors |
| 03/14/2007 | EP1163240B1 Tricyclic benzoylpyrazole derivatives used as a herbicide |
| 03/14/2007 | CN1930172A Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein |
| 03/14/2007 | CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes |
| 03/14/2007 | CN1927866A Preparation method of methyl thienotetrahydropyridinacetate |
| 03/14/2007 | CN1927865A Synthesis method of thienotetrahydropyridine acetonitrile |
| 03/14/2007 | CN1927864A Preparation method of thienotetrahydropyridinacetic acid and salt thereof |
| 03/14/2007 | CN1927863A Preparation method of thienotetrahydropyridinacetic acid and salt thereof |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | CA2116388C Treatment for viral diseases |
| 03/08/2007 | WO2007025709A2 Organic compounds |
| 03/08/2007 | WO2007003782A3 Novel functionalised transfer agents for controlled radical polymerisation raft, raft methods using said transfer agents and polymers obtainable thereby |
| 03/08/2007 | US20070054939 N-ethyl-N-(1-methyl-2-oxo-2-phenylethyl)2-[1(4'-trifluoromethylbiphenyl-2-carbonyl)piperid-4-yl]thiazole-4-carbamate ; hypertriglyceridaemia, hypercholesterolaemia, or dyslipidaemia associated with diabetes; microsomal triglyceride transfer protein (MTP), |
| 03/08/2007 | US20070054881 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/08/2007 | CA2620864A1 Raf inhibitor compounds and methods of use thereof |